Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2011, Article ID 919067, 4 pages
http://dx.doi.org/10.1155/2011/919067
Case Report

Accidental Subcutaneous Remifentanil Infusion as a Cause of Delayed Awakening after Craniotomy

1Department of Anesthesiology, University Medical Center at Princeton, 253 Witherspoon Street, Princeton, NJ 08540, USA
2Department of Anesthesiology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA

Received 27 July 2011; Accepted 12 September 2011

Academic Editors: U. Buyukkocak, M. J. C. Carmona, M. Coburn, and C. C. Lu

Copyright © 2011 Alexander Wolfson and Cephas Swamidoss. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Black, F. K. Enneking, and R. F. Cucchiara, “Failure to awaken after general anesthesia due to cerebrovascular events,” Journal of Neurosurgical Anesthesiology, vol. 10, no. 1, pp. 10–15, 1998. View at Google Scholar · View at Scopus
  2. J. K. Denlinger, “Prolonged emergence and failure to regain consciousness,” in Complications in Anesthesiology, N. Gravenstein and R. R. Kirby, Eds., pp. 441–451, Lippincott-Raven, Philadelphia, Pa, USA, 1996. View at Google Scholar
  3. G. Schneider and P. S. Sebel, “Monitoring depth of anesthesia,” European Journal of Anesthesiology, supplement 15, pp. 21–28, 1997. View at Google Scholar
  4. R. A. Radtke, C. W. Erwin, and R. H. Wilkins, “Intraoperative brainstem auditory evoked potentials: significant decrease in postoperative morbidity,” Neurology, vol. 39, no. 2, pp. 187–191, 1989. View at Google Scholar · View at Scopus
  5. D. H. Slavit, S. G. Harner, C. M. Harper, and C. W. Beatty, “Auditory monitoring during acoustic neuroma removal,” Archives of Otolaryngology - Head and Neck Surgery, vol. 117, no. 10, pp. 1153–1157, 1991. View at Google Scholar · View at Scopus
  6. T. B. Sloan, “Anesthetic effects on electrophysiologic recordings,” Journal of Clinical Neurophysiology, vol. 15, no. 3, pp. 217–226, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Grillo, N. Bruder, P. Auquier, D. Pellissier, and F. Gouin, “Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients,” Anesthesia and Analgesia, vol. 96, no. 4, pp. 1145–1149, 2003. View at Google Scholar · View at Scopus
  8. D. Song and P. F. White, “Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery,” Journal of Clinical Anesthesia, vol. 11, no. 5, pp. 364–367, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Lang, A. Kapila, D. Shlugman, J. F. Hoke, P. S. Sebel, and P. S. A. Glass, “Reduction of isoflurane minimal alveolar concentration by remifentanil,” Anesthesiology, vol. 85, no. 4, pp. 721–728, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Gesztesi, B. L. Mootz, and P. F. White, “The use of a remifentanil infusion for hemodynamic control during intracranial surgery,” Anesthesia and Analgesia, vol. 89, no. 5, pp. 1282–1287, 1999. View at Google Scholar · View at Scopus
  11. L. G. Michelsen, M. Salmenperä, C. C. Hug, F. Szlam, and D. VanderMeer, “Anesthetic potency of remifentanil in dogs,” Anesthesiology, vol. 84, no. 4, pp. 865–872, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. W. E. Hoffman, F. Cunningham, M. K. James, V. L. Baughman, and R. F. Albrecht, “Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide,” Anesthesiology, vol. 79, no. 1, pp. 107–113, 1993. View at Google Scholar · View at Scopus
  13. Anonymous, “Remifentanil approved for anesthesia use [news],” American Journal of Health System Pharmacy, vol. 53, p. 2250, 1996. View at Google Scholar
  14. T. D. Egan, “Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000,” Current Opinion in Anaesthesiology, vol. 13, no. 4, pp. 449–455, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. Abbott Laboratories, Ultiva, Remifentanil hydrochloride physician insert, Abbott Laboratories, North Chicago, Ill, USA, 2001.
  16. L. G. Michelsen and C. C. Hug Jr., “The pharmacokinetics of remifentanil,” Journal of Clinical Anesthesia, vol. 8, no. 8, pp. 679–682, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. T. D. Egan, B. Huizinga, S. K. Gupta et al., “Remifentanil pharmacokinetics in obese versus lean patients,” Anesthesiology, vol. 89, no. 3, pp. 562–573, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. A. Glass, I. A. Iselin-Chaves, D. Goodman, E. Delong, and D. J. Hermann, “Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect,” Anesthesiology, vol. 90, no. 6, pp. 1556–1563, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. F. Hoke, F. Cunningham, M. K. James, K. T. Muir, and W. E. Hoffman, “Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs,” Journal of Pharmacology and Experimental Therapeutics, vol. 281, no. 1, pp. 226–232, 1997. View at Google Scholar · View at Scopus
  20. K. Selinger, R. L. Nation, and A. Smith, “Enzymatic and chemical hydrolysis of Remifentnil,” Anesthesiology, vol. 83, p. A385, 1995. View at Google Scholar
  21. M. K. James, P. L. Feldman, S. V. Schuster, J. M. Bilotta, M. F. Brackeen, and H. J. Leighton, “Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues,” Journal of Pharmacology and Experimental Therapeutics, vol. 259, no. 2, pp. 712–718, 1991. View at Google Scholar · View at Scopus
  22. R. E. Kan, S. C. Hughes, M. A. Rosen, C. Kessin, P. G. Preston, and E. P. Lobo, “Intravenous remifentanil: placental transfer, maternal and neonatal effects,” Anesthesiology, vol. 88, no. 6, pp. 1467–1474, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. R. L. Stiller, P. J. Davis, F. X. McGowan et al., “In vivo metabolism of Remifentanil: the effects of pseudocholinesterase deficiency,” Anesthesiology, vol. 83, p. A381, 1995. View at Google Scholar
  24. J. F. Hoke, D. Shlugman, M. Dershwitz et al., “Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers,” Anesthesiology, vol. 87, no. 3, pp. 533–541, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Dershwitz, J. F. Hoke, C. E. Rosow et al., “Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease,” Anesthesiology, vol. 84, no. 4, pp. 812–820, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Russell, D. Royston, P. H. Rees, S. K. Gupta, and G. N. C. Kenny, “Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil,” British Journal of Anaesthesia, vol. 79, no. 4, pp. 456–459, 1997. View at Google Scholar · View at Scopus
  27. R. T. Penson, S. P. Joel, M. Roberts, A. Gloyne, S. Beckwith, and M. L. Slevin, “The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide,” British Journal of Clinical Pharmacology, vol. 53, no. 4, pp. 347–354, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C. S. Waldman, J. R. Eason, E. Rambohul et al., “Serum morphine levels—a comparison between continuous SQ and IV infusion in post-operative analgesia,” Anaesthesia, vol. 39, pp. 768–771, 1984. View at Google Scholar
  29. G. Cucchiaro and R. A. Beers, “Recrudescence of opioid effects after intraoperative remifentanil infusion complicated by infiltration of the intravenous catheter,” Anesthesia & Analgesia, vol. 87, p. 1458, 1998. View at Google Scholar
  30. R. Osborne, S. Joel, D. Trew, and M. Slevin, “Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide,” Clinical Pharmacology and Therapeutics, vol. 47, no. 1, pp. 12–19, 1990. View at Google Scholar · View at Scopus
  31. S. N. Davis, “Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas,” in Goodman and Gilman’s The Pharmacological Basis of Therapeutics, L. Brunton and J. Lazo, Eds., pp. 1628–1629, McGraw-Hill, Columbus, Ohio, USA, 11th edition, 2006. View at Google Scholar
  32. T. D. Egan, C. F. Minto, D. J. Hermann, J. Barr, K. T. Muir, and S. L. Shafer, “Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers,” Anesthesiology, vol. 84, no. 4, pp. 821–833, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. P. S. A. Glass, D. Hardman, Y. Kamiyama et al., “Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B),” Anesthesia and Analgesia, vol. 77, no. 5, pp. 1031–1040, 1993. View at Google Scholar · View at Scopus
  34. D. R. Drover and H. J. M. Lemmens, “Population pharmacodymics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery,” Anesthesiology, vol. 89, no. 4, pp. 869–877, 1998. View at Publisher · View at Google Scholar · View at Scopus